The use of androgenic steroids, peptides and other performance- and image-enhancing drugs is becoming common for some groups of Australian males, placing their health at risk and presenting challenges to health professionals.
Patients may not reveal their use of performance- and image-enhancing drugs for various reasons, which may complicate the diagnosis and treatment of related health problems. The complex combinations and patterns of use of performance- and image-enhancing drugs can cause further complications.
Practitioners who are aware of patients’ use of performance- and image-enhancing drugs must avoid complicity.
The ultimate goal of care for users of performance- and image-enhancing drugs should be cessation, with treatment of adverse effects and counselling until that time.
Demonstrate how to counsel patients who use performance and image-enhancing drugs
Implement testing to detect adverse effects of the use of performance and image-enhancing drugs
Display capacity to influence positive behaviour change of patients who use performance and image-enhancing drugs including the cessation of the use of performance- and image-enhancing drugs
Outline strategies to minimise harm associated with performance and image-enhancing drug use.
This is a Medcast Continuing Medical Education (CME) course.
This course is formally accredited with RACGP and ACRRM.
RACGP Activity ID: 1379018
ACCRM Activity ID: 38517
Live Webinar
10/12/2025 7:00 pm (Sydney time)
Australia/Sydney
Duration: 1 HR CPD
Educational Activities: 1 hours
Program Level Requirements: Professionalism and Ethical Practice
Areas Of Interest: Men's health
Medical Practitioners
Or follow us on social media
All your CPD in one easy membership.
From $35/month